Stay updated with breaking news from Nasdaq Atha. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Athira Pharma, Inc. (NASDAQ:ATHA – Get Rating) insider Andrew Gengos purchased 20,012 shares of Athira Pharma stock in a transaction that occurred on Friday, June 2nd. The stock was acquired at an average price of $2.82 per share, with a total value of $56,433.84. Following the transaction, the insider now owns 20,012 shares in the […]
Athira Pharma, Inc. (NASDAQ:ATHA – Get Rating) insider Andrew Gengos bought 45,000 shares of the business’s stock in a transaction that occurred on Monday, June 5th. The shares were bought at an average price of $3.00 per share, with a total value of $135,000.00. Following the completion of the purchase, the insider now owns 65,012 […]
GSA Capital Partners LLP raised its holdings in Athira Pharma, Inc. (NASDAQ:ATHA – Get Rating) by 59.9% during the fourth quarter, HoldingsChannel.com reports. The fund owned 270,989 shares of the company’s stock after purchasing an additional 101,471 shares during the period. GSA Capital Partners LLP’s holdings in Athira Pharma were worth $859,000 at the end […]
Athira Pharma, Inc. (NASDAQ:ATHA – Get Rating) was the recipient of a significant drop in short interest in the month of May. As of May 15th, there was short interest totalling 2,050,000 shares, a drop of 5.5% from the April 30th total of 2,170,000 shares. Currently, 5.8% of the shares of the company are sold […]
Athira Pharma (NASDAQ:ATHA – Get Rating) had its target price cut by Mizuho from $6.00 to $5.00 in a research note released on Monday morning, The Fly reports. Separately, BTIG Research lowered their price target on shares of Athira Pharma from $33.00 to $10.00 and set a buy rating on the stock in a report […]